NEW YORK (GenomeWeb) – Telemedicine services provider Medical Innovation Holdings announced today that its subsidiary BKare Diagnostics has signed a marketing and services agreement with Vantari Genetics.

Under the terms of the deal, BKare will provide marketing and certain other services to Vantari, which offers genetic testing, as well as molecular laboratory and toxicology services.

Additional terms of the arrangement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.